Comparison of Transdermal and Oral Estrogens in Adolescent Girls With Ovarian Failure

Ovarian Failure, Premature Clinical Trial

Official title:
Comparison of Transdermal and Oral Estrogens in Adolescents With Ovarian Failure

Status Completed

Clinical Trial Summary

To directly compare the safety (by laboratory evaluation) and efficacy (feminization and growth) of three commonly used estrogen preparations in adolescent patients with ovarian failure, either due to congenital causes (Turner syndrome) or medical therapies. We hypothesize that transdermal estrogen will have equivalent efficacy and a more favorable safety profile in comparison with conventional oral estrogen replacement.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01023178
Study type	Interventional
Source	Stanford University
Contact
Status	Completed
Phase	N/A
Start date	February 2007
Completion date	June 2013

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT02780791` - Maturation of Follicles After Transplantation of Ovarian Tissue Into the Pelvic Wall and the Ovary	N/A
Completed	`NCT00471731` - Dry Eye in Women With Turner Syndrome and Women With Premature Ovarian Failure	N/A
Enrolling by invitation	`NCT04009473` - Stem Cell Therapy and Growth Factor Ovarian in Vitro Activation	Phase 1/Phase 2
Recruiting	`NCT04031456` - Autologous PRP Infusion May Restore Ovarian Function and May Promote Folliculogenesis in POI Patients	Phase 2/Phase 3
Completed	`NCT05443282` - Ovarian Reserve and Matrix Metalloproteinases